Christian L. Brand
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism
Most-Cited Works
- → Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury(2005)625 cited
- → Persistent Organic Pollutant Exposure Leads to Insulin Resistance Syndrome(2009)389 cited
- → Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.(1998)312 cited
- → Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats(2005)213 cited
- → GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics(2003)200 cited
- → A novel high-affinity peptide antagonist to the insulin receptor(2008)154 cited
- → Capsaicin‐sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes(2007)147 cited
- → Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity(2002)142 cited
- → Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats(1994)137 cited
- → Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function(2006)120 cited